NVO
Novo Nordisk A/S
Stock
$37.32−0.08 (−0.21%)Close Oct 2, 2026
- Free cash flow, 2025
- DKK 59.0B
- YoY, 2025
- −20.1%
- 5-year CAGR
- +5.0%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | DKK 59.0B | −20.1% |
| 2024 | DKK 73.8B | −11.2% |
| 2023 | DKK 83.1B | +24.5% |
| 2022 | DKK 66.7B | +37.1% |
| 2021 | DKK 48.7B | +5.5% |
| 2020 | DKK 46.1B | +21.9% |
| 2019 | DKK 37.9B | — |